Cargando…

Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia

The immune system of patients infected by SARS-CoV-2 is severely impaired. Detailed investigation of T cells and cytokine production in patients affected by COVID-19 pneumonia are urgently required. Here we show that, compared with healthy controls, COVID-19 patients’ T cell compartment displays sev...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Biasi, Sara, Meschiari, Marianna, Gibellini, Lara, Bellinazzi, Caterina, Borella, Rebecca, Fidanza, Lucia, Gozzi, Licia, Iannone, Anna, Lo Tartaro, Domenico, Mattioli, Marco, Paolini, Annamaria, Menozzi, Marianna, Milić, Jovana, Franceschi, Giacomo, Fantini, Riccardo, Tonelli, Roberto, Sita, Marco, Sarti, Mario, Trenti, Tommaso, Brugioni, Lucio, Cicchetti, Luca, Facchinetti, Fabio, Pietrangelo, Antonello, Clini, Enrico, Girardis, Massimo, Guaraldi, Giovanni, Mussini, Cristina, Cossarizza, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338513/ https://www.ncbi.nlm.nih.gov/pubmed/32632085 http://dx.doi.org/10.1038/s41467-020-17292-4

Ejemplares similares

Patients Recovering from Severe COVID-19 Develop a Polyfunctional Antigen-Specific CD4+ T Cell Response
por: Paolini, Annamaria, et al.
Publicado: (2022)

Plasma Cytokine Atlas Reveals the Importance of TH2 Polarization and Interferons in Predicting COVID-19 Severity and Survival
por: Gibellini, Lara, et al.
Publicado: (2022)

Author Correction: Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection
por: De Biasi, Sara, et al.
Publicado: (2021)

Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection
por: De Biasi, Sara, et al.
Publicado: (2021)

Prognostic immune markers identifying patients with severe COVID-19 who respond to tocilizumab
por: De Biasi, Sara, et al.
Publicado: (2023)

Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID‐19 pneumonia
por: Gibellini, Lara, et al.
Publicado: (2020)

Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination
por: Lo Tartaro, Domenico, et al.
Publicado: (2023)

Molecular and cellular immune features of aged patients with severe COVID-19 pneumonia
por: Lo Tartaro, Domenico, et al.
Publicado: (2022)

Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator
por: Mussini, Cristina, et al.
Publicado: (2021)

Evaluating immunological and inflammatory changes of treatment-experienced people living with HIV switching from first-line triple cART regimens to DTG/3TC vs. B/F/TAF: the DEBATE trial
por: Cossarizza, Andrea, et al.
Publicado: (2023)

First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy
por: Meschiari, Marianna, et al.
Publicado: (2022)

Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV-2 infection: retrospective cohort study
por: Coloretti, Irene, et al.
Publicado: (2021)

Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection
por: Mussini, Cristina, et al.
Publicado: (2021)

The Association of Procalcitonin and C-Reactive Protein with Bacterial Infections Acquired during Intensive Care Unit Stay in COVID-19 Critically Ill Patients
por: Campani, Simone, et al.
Publicado: (2023)

Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study
por: Mussini, Cristina, et al.
Publicado: (2023)

Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia
por: Busani, Stefano, et al.
Publicado: (2020)

Tocilizumab in patients with severe COVID-19: a retrospective cohort study
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Critical COVID-19 patients through first, second, and third wave: retrospective observational study comparing outcomes in intensive care unit
por: Coloretti, Irene, et al.
Publicado: (2023)

A Comprehensive Analysis of Cytokine Network in Centenarians
por: Pinti, Marcello, et al.
Publicado: (2023)

T Cell Activation but Not Polyfunctionality after Primary HIV Infection Predicts Control of Viral Load and Length of the Time without Therapy
por: Cossarizza, Andrea, et al.
Publicado: (2012)

Cell Death in Coronavirus Infections: Uncovering Its Role during COVID-19
por: Paolini, Annamaria, et al.
Publicado: (2021)

Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients
por: Riva, Giovanni, et al.
Publicado: (2021)

Adjunctive Immunotherapy With Polyclonal Ig-M Enriched Immunoglobulins for Septic Shock: From Bench to Bedside. The Rationale for a Personalized Treatment Protocol
por: Busani, Stefano, et al.
Publicado: (2021)

Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality
por: Gatto, Ilenia, et al.
Publicado: (2022)

Re: ‘Methodological evaluation of bias in observational COVID-19 studies on drug effectiveness’ by Wolkewitz et al.
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2021)

Reliable and Accurate CD4+ T Cell Count and Percent by the Portable Flow Cytometer CyFlow MiniPOC and “CD4 Easy Count Kit-Dry”, as Revealed by the Comparison with the Gold Standard Dual Platform Technology
por: Nasi, Milena, et al.
Publicado: (2015)

Redistribution of CD8+ T cell subsets in metastatic renal cell carcinoma patients treated with anti‐PD‐1 therapy
por: De Biasi, Sara, et al.
Publicado: (2022)

Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature
por: Bacca, Erica, et al.
Publicado: (2021)

Tocilizumab for severe COVID-19 pneumonia – Authors' reply
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Role of Selective Digestive Decontamination in the Prevention of Ventilator-Associated Pneumonia in COVID-19 Patients: A Pre-Post Observational Study
por: Biagioni, Emanuela, et al.
Publicado: (2023)

Epidemiology and Risk Factors Associated With Mortality in Consecutive Patients With Bacterial Bloodstream Infection: Impact of MDR and XDR Bacteria
por: Santoro, Antonella, et al.
Publicado: (2020)

The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study
por: Milic, Jovana, et al.
Publicado: (2021)

Risk Factors for Pulmonary Air Leak and Clinical Prognosis in Patients With COVID-19 Related Acute Respiratory Failure: A Retrospective Matched Control Study
por: Tonelli, Roberto, et al.
Publicado: (2022)

Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia—Challenges, strengths, and opportunities in a global health emergency
por: Ferrari, Davide, et al.
Publicado: (2020)

Anti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with Psoriasis
por: Gibellini, Lara, et al.
Publicado: (2016)

A Fatal Case of Pseudomonas aeruginosa Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature Review
por: Barp, Nicole, et al.
Publicado: (2023)

Single-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors
por: Gibellini, Lara, et al.
Publicado: (2020)

Evidence for mitochondrial Lonp1 expression in the nucleus
por: Gibellini, Lara, et al.
Publicado: (2022)

Association between Pulmonary Aspergillosis and Cytomegalovirus Reactivation in Critically Ill COVID-19 Patients: A Prospective Observational Cohort Study
por: Caciagli, Valeria, et al.
Publicado: (2023)

Synthesis and Anticancer Activity of CDDO and CDDO-Me, Two Derivatives of Natural Triterpenoids
por: Borella, Rebecca, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s615cs8alfieiduj37q089u9vb